Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | CDK1 | P06493 | 2/20 | 0.41 |
| ▸ | CCNB1 | P14635 | 2/20 | 0.41 |
| ▸ | CCNA2 | P20248 | 2/20 | 0.41 |
| ▸ | CDK2 | P24941 | 2/20 | 0.41 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.36 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | MAOB | P27338 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.34 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.34 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.34 |
| ▸ | RGS12 | O14924 | 2/20 | 0.34 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.34 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7973683 | 0.91 | MAPK1 (0.56) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL12286212 | 0.83 | MAPK1 (0.46) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL14241127 | 0.83 | MAPK1 (0.46) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL16480957 | 0.83 | MAPK1 (0.46) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL472171 | 0.83 | MAPK1 (0.46) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL13895288 | 0.79 | MAPK1 (0.44) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL7927729 | 0.78 | ALDH1A1 (0.44) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL19695510 | 0.78 | ALDH1A1 (0.44) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL13460203 | 0.78 | MAPK1 (0.57) | MAPK1CDK1CCNB1CCNA2CDK2 | |
| SCHEMBL13188777 | 0.77 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105777671-B | Continuous process for epoxidizing olefins using supported heteropolyacids | 长春人造树脂厂股份有限公司 | 2021-01-15 | — | — | CN | disclosed |
| US-20170357156-A1 | NEGATIVE TONE PHOTOSENSITIVE COMPOSITIONS | PROMERUS, LLC (US) | 2017-12-14 | — | — | US | disclosed |
| US-9499505-B2 | Process for the epoxidation of olefins | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-11-22 | — | — | US | disclosed |
| US-9499505-B2 | Process for the epoxidation of olefins | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-11-22 | — | — | US | disclosed |
| US-9499505-B2 | Process for the epoxidation of olefins | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-11-22 | — | — | US | disclosed |
| US-20160177023-A1 | CONTINUOUS PROCESS OF OLEFINIC EPOXIDATION BY SUPPORTED HETEROPOLY ACID | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-06-23 | — | — | US | disclosed |
| US-20160177023-A1 | CONTINUOUS PROCESS OF OLEFINIC EPOXIDATION BY SUPPORTED HETEROPOLY ACID | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-06-23 | — | — | US | disclosed |
| US-20160177023-A1 | CONTINUOUS PROCESS OF OLEFINIC EPOXIDATION BY SUPPORTED HETEROPOLY ACID | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-06-23 | — | — | US | disclosed |
| US-20160083360-A1 | PROCESS FOR THE EPOXIDATION OF OLEFINS | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-03-24 | — | — | US | disclosed |
| US-20160083360-A1 | PROCESS FOR THE EPOXIDATION OF OLEFINS | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-03-24 | — | — | US | disclosed |
| US-20160083360-A1 | PROCESS FOR THE EPOXIDATION OF OLEFINS | CHANG CHUN PLASTICS CO., LTD. (TW) | 2016-03-24 | — | — | US | disclosed |
| WO-2003057677-A1 | ANTI-RETROVIRAL 5,6-DISUBSTITUTED ACYCLOPYRIMIDINE NUCLEOSIDE DERIVATIVES | SYDDANSK UNIVERSITET (DK) | 2003-07-17 | — | — | WO | disclosed |
| EP-0532896-B1 | Cleavable diepoxide for removable device protection in electronic packaging | IBM (US) | 1997-03-19 | — | — | EP | disclosed |
| US-5560934-A | CURED REACTION PRODUCT CONTAINING A CYCLIC ANHYDRIDE CURING AGENT AND AN AMINE PROMOTER; USED FOR ENCAPSULATING ELECTRONIC CHIPS | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1996-10-01 | — | — | US | disclosed |
| US-5512613-A | CURED COMPOSITION COMPRISING REACTION PRODUCT OF DIEPOXIDE HAVING ACETAL LINKAGES, CYCLIC DICARBOXYLIC ANHYDRIDE CURING AGENT, 1,3-DIAZA COMPOUND, HYDROXY FUNCTIONAL INITIATOR; REMOVABLE IN ACIDIC SOLVENTS | INTERNATIONAL BUSINESS MACHINES CORPORATION (US) | 1996-04-30 | — | — | US | disclosed |
| EP-0532896-A2 | Cleavable diepoxide for removable device protection in electronic packaging | International Business Machines Corporation (US) | 1993-03-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083360-A1 | PROCESS FOR THE EPOXIDATION OF OLEFINS | HSF1, HMOX1, HSPH1 | MAPK1 1550/4885CDK1 2739/4885CCNB1 2746/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.